180 related articles for article (PubMed ID: 18001828)
1. Development of lipid particles targeted via sugar-lipid conjugates as novel nuclear gene delivery system.
Masuda T; Akita H; Nishio T; Niikura K; Kogure K; Ijiro K; Harashima H
Biomaterials; 2008 Feb; 29(6):709-23. PubMed ID: 18001828
[TBL] [Abstract][Full Text] [Related]
2. Octaarginine-modified multifunctional envelope-type nano device for siRNA.
Nakamura Y; Kogure K; Futaki S; Harashima H
J Control Release; 2007 Jun; 119(3):360-7. PubMed ID: 17478000
[TBL] [Abstract][Full Text] [Related]
3. Development of a non-viral multifunctional envelope-type nano device by a novel lipid film hydration method.
Kogure K; Moriguchi R; Sasaki K; Ueno M; Futaki S; Harashima H
J Control Release; 2004 Aug; 98(2):317-23. PubMed ID: 15262422
[TBL] [Abstract][Full Text] [Related]
4. Enhanced gene expression by a novel stearylated INF7 peptide derivative through fusion independent endosomal escape.
El-Sayed A; Masuda T; Khalil I; Akita H; Harashima H
J Control Release; 2009 Sep; 138(2):160-7. PubMed ID: 19465073
[TBL] [Abstract][Full Text] [Related]
5. Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid.
Hatakeyama H; Akita H; Kogure K; Oishi M; Nagasaki Y; Kihira Y; Ueno M; Kobayashi H; Kikuchi H; Harashima H
Gene Ther; 2007 Jan; 14(1):68-77. PubMed ID: 16915290
[TBL] [Abstract][Full Text] [Related]
6. Functional improvement of an IRQ-PEG-MEND for delivering genes to the lung.
Ishitsuka T; Akita H; Harashima H
J Control Release; 2011 Aug; 154(1):77-83. PubMed ID: 21619903
[TBL] [Abstract][Full Text] [Related]
7. Octaarginine- and pH sensitive fusogenic peptide-modified nanoparticles for liver gene delivery.
Khalil IA; Hayashi Y; Mizuno R; Harashima H
J Control Release; 2011 Dec; 156(3):374-80. PubMed ID: 21864599
[TBL] [Abstract][Full Text] [Related]
8. Systemic delivery of siRNA to tumors using a lipid nanoparticle containing a tumor-specific cleavable PEG-lipid.
Hatakeyama H; Akita H; Ito E; Hayashi Y; Oishi M; Nagasaki Y; Danev R; Nagayama K; Kaji N; Kikuchi H; Baba Y; Harashima H
Biomaterials; 2011 Jun; 32(18):4306-16. PubMed ID: 21429576
[TBL] [Abstract][Full Text] [Related]
9. Multifunctional envelope-type nano device (MEND) as a non-viral gene delivery system.
Kogure K; Akita H; Yamada Y; Harashima H
Adv Drug Deliv Rev; 2008 Mar; 60(4-5):559-71. PubMed ID: 18037529
[TBL] [Abstract][Full Text] [Related]
10. Construction of a multifunctional envelope-type nano device by a SUV*-fusion method.
Sasaki K; Kogure K; Chaki S; Kihira Y; Ueno M; Harashima H
Int J Pharm; 2005 May; 296(1-2):142-50. PubMed ID: 15885466
[TBL] [Abstract][Full Text] [Related]
11. Multi-layered nanoparticles for penetrating the endosome and nuclear membrane via a step-wise membrane fusion process.
Akita H; Kudo A; Minoura A; Yamaguti M; Khalil IA; Moriguchi R; Masuda T; Danev R; Nagayama K; Kogure K; Harashima H
Biomaterials; 2009 May; 30(15):2940-9. PubMed ID: 19261326
[TBL] [Abstract][Full Text] [Related]
12. Non-linear pharmacodynamics in a non-viral gene delivery system: positive non-linear relationship between dose and transfection efficiency.
Moriguchi R; Kogure K; Iwasa A; Akita H; Harashima H
J Control Release; 2006 Feb; 110(3):605-9. PubMed ID: 16360229
[TBL] [Abstract][Full Text] [Related]
13. Improving in vivo hepatic transfection activity by controlling intracellular trafficking: the function of GALA and maltotriose.
Akita H; Masuda T; Nishio T; Niikura K; Ijiro K; Harashima H
Mol Pharm; 2011 Aug; 8(4):1436-42. PubMed ID: 21598999
[TBL] [Abstract][Full Text] [Related]
14. Nuclear localisation and pDNA condensation in non-viral gene delivery.
Collins E; Birchall JC; Williams JL; Gumbleton M
J Gene Med; 2007 Apr; 9(4):265-74. PubMed ID: 17397103
[TBL] [Abstract][Full Text] [Related]
15. A multifunctional envelope-type nanodevice for use in nanomedicine: concept and applications.
Nakamura T; Akita H; Yamada Y; Hatakeyama H; Harashima H
Acc Chem Res; 2012 Jul; 45(7):1113-21. PubMed ID: 22324902
[TBL] [Abstract][Full Text] [Related]
16. Multifunctional envelope-type nano device for non-viral gene delivery: concept and application of Programmed Packaging.
Kogure K; Akita H; Harashima H
J Control Release; 2007 Oct; 122(3):246-51. PubMed ID: 17651856
[TBL] [Abstract][Full Text] [Related]
17. Multifunctional envelope-type nano device (MEND) for organelle targeting via a stepwise membrane fusion process.
Yamada Y; Akita H; Harashima H
Methods Enzymol; 2012; 509():301-26. PubMed ID: 22568912
[TBL] [Abstract][Full Text] [Related]
18. PAMAM-triamcinolone acetonide conjugate as a nucleus-targeting gene carrier for enhanced transfer activity.
Ma K; Hu MX; Qi Y; Zou JH; Qiu LY; Jin Y; Ying XY; Sun HY
Biomaterials; 2009 Oct; 30(30):6109-18. PubMed ID: 19656564
[TBL] [Abstract][Full Text] [Related]
19. A touch-and-go lipid wrapping technique in microfluidic channels for rapid fabrication of multifunctional envelope-type gene delivery nanodevices.
Kitazoe K; Wang J; Kaji N; Okamoto Y; Tokeshi M; Kogure K; Harashima H; Baba Y
Lab Chip; 2011 Oct; 11(19):3256-62. PubMed ID: 21829858
[TBL] [Abstract][Full Text] [Related]
20. Tissue-specific and transcription factor-mediated nuclear entry of DNA.
Miller AM; Dean DA
Adv Drug Deliv Rev; 2009 Jul; 61(7-8):603-13. PubMed ID: 19393704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
